BindingDB logo
myBDB logout

Patent code US10166214

Compile Data Set for Download or QSAR

Found 284 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311944
PNG
(US10166214, Example 80)
Show SMILES Cc1ncc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H23N3O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23)/t14-,15+,17+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
1.20n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311888
PNG
(US10166214, Example 24)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nccc2ccccc12
Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)15-13-9-19-10-14(13)15)16-12-6-4-3-5-11(12)7-8-20-16/h3-8,13-15,19H,9-10H2,1-2H3,(H,21,22)/t13-,14+,15+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
2.90n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311990
PNG
(US10166214, Example 126)
Show SMILES Cc1cccn2c(ncc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C17H22N4O/c1-10-5-4-6-21-13(10)9-19-16(21)17(2,3)20-15(22)14-11-7-18-8-12(11)14/h4-6,9,11-12,14,18H,7-8H2,1-3H3,(H,20,22)/t11-,12+,14+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311971
PNG
(US10166214, Example 107)
Show SMILES Cc1cccc2c(nn(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-11-15(10)22(4)21-16(11)18(2,3)20-17(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,20,23)/t12-,13+,14+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
3.40n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311957
PNG
(US10166214, Example 93)
Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
3.60n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM50081058
PNG
(CHEMBL3421842 | US10166214, Example 22)
Show SMILES Cc1cc2ccccc2c(n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
3.70n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM50081055
PNG
(CHEMBL3421843 | US10166214, Example 49)
Show SMILES Cn1nc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
4.5n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311992
PNG
(US10166214, Example 128)
Show SMILES Cc1cccn2c(nc(C3CC3)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C20H26N4O/c1-11-5-4-8-24-17(11)16(12-6-7-12)22-19(24)20(2,3)23-18(25)15-13-9-21-10-14(13)15/h4-5,8,12-15,21H,6-7,9-10H2,1-3H3,(H,23,25)/t13-,14+,15+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
7.60n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311885
PNG
(US10166214, Example 21)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1ccnc2ccccc12
Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)16-12-9-19-10-13(12)16)14-7-8-20-15-6-4-3-5-11(14)15/h3-8,12-13,16,19H,9-10H2,1-2H3,(H,21,22)/t12-,13+,16+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
10.8n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311958
PNG
(US10166214, Example 94)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1n[nH]c2ccccc12
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
15.9n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM312012
PNG
(US10166214, Example 148)
Show SMILES Cc1nc(c2cccc(C)c2n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H24N4O/c1-10-6-5-7-12-16(10)21-11(2)22-17(12)19(3,4)23-18(24)15-13-8-20-9-14(13)15/h5-7,13-15,20H,8-9H2,1-4H3,(H,23,24)/t13-,14+,15+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
32.3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311904
PNG
(US10166214, Example 40)
Show SMILES Cc1ccccc1OCC(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C17H24N2O2/c1-11-6-4-5-7-14(11)21-10-17(2,3)19-16(20)15-12-8-18-9-13(12)15/h4-7,12-13,15,18H,8-10H2,1-3H3,(H,19,20)/t12-,13+,15+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
37.1n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311911
PNG
(US10166214, Example 47)
Show SMILES Cc1cccnc1OCC(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C16H23N3O2/c1-10-5-4-6-18-15(10)21-9-16(2,3)19-14(20)13-11-7-17-8-12(11)13/h4-6,11-13,17H,7-9H2,1-3H3,(H,19,20)/t11-,12+,13+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
39.9n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM50081060
PNG
(CHEMBL3421844 | US10166214, Example 101)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1noc2c(F)cccc12
Show InChI InChI=1S/C16H18FN3O2/c1-16(2,19-15(21)12-9-6-18-7-10(9)12)14-8-4-3-5-11(17)13(8)22-20-14/h3-5,9-10,12,18H,6-7H2,1-2H3,(H,19,21)/t9-,10+,12+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
46.2n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311927
PNG
(US10166214, Example 63)
Show SMILES CC(C)(COc1cnccc1C(F)(F)F)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C16H20F3N3O2/c1-15(2,22-14(23)13-9-5-21-6-10(9)13)8-24-12-7-20-4-3-11(12)16(17,18)19/h3-4,7,9-10,13,21H,5-6,8H2,1-2H3,(H,22,23)/t9-,10+,13+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
68.9n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM50081059
PNG
(CHEMBL3421845 | US10166214, Example 138)
Show SMILES Cc1nc(c2ccccc2n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C18H22N4O/c1-10-20-14-7-5-4-6-11(14)16(21-10)18(2,3)22-17(23)15-12-8-19-9-13(12)15/h4-7,12-13,15,19H,8-9H2,1-3H3,(H,22,23)/t12-,13+,15+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
70.3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311942
PNG
(US10166214, Example 78)
Show SMILES Cc1cc2cccnc2c(n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C18H22N4O/c1-10-7-11-5-4-6-20-15(11)16(21-10)18(2,3)22-17(23)14-12-8-19-9-13(12)14/h4-7,12-14,19H,8-9H2,1-3H3,(H,22,23)/t12-,13+,14+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
97.2n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311920
PNG
(US10166214, Example 56)
Show SMILES CC(C)(COc1nccc2ccccc12)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H23N3O2/c1-19(2,22-17(23)16-14-9-20-10-15(14)16)11-24-18-13-6-4-3-5-12(13)7-8-21-18/h3-8,14-16,20H,9-11H2,1-2H3,(H,22,23)/t14-,15+,16+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
100n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311875
PNG
(US10166214, Example 11)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nc2ccc(Cl)cc2[nH]1
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
106n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 4


(Homo sapiens (Human))
BDBM311889
PNG
(US10166214, Example 25)
Show SMILES Cc1cccnc1C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C15H21N3O/c1-9-5-4-6-17-13(9)15(2,3)18-14(19)12-10-7-16-8-11(10)12/h4-6,10-12,16H,7-8H2,1-3H3,(H,18,19)/t10-,11+,12+
KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
114n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311944
PNG
(US10166214, Example 80)
Show SMILES Cc1ncc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H23N3O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23)/t14-,15+,17+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
508n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM50081058
PNG
(CHEMBL3421842 | US10166214, Example 22)
Show SMILES Cc1cc2ccccc2c(n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
848n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311992
PNG
(US10166214, Example 128)
Show SMILES Cc1cccn2c(nc(C3CC3)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C20H26N4O/c1-11-5-4-8-24-17(11)16(12-6-7-12)22-19(24)20(2,3)23-18(25)15-13-9-21-10-14(13)15/h4-5,8,12-15,21H,6-7,9-10H2,1-3H3,(H,23,25)/t13-,14+,15+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
1.10E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311888
PNG
(US10166214, Example 24)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nccc2ccccc12
Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)15-13-9-19-10-14(13)15)16-12-6-4-3-5-11(12)7-8-20-16/h3-8,13-15,19H,9-10H2,1-2H3,(H,21,22)/t13-,14+,15+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
2.82E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311920
PNG
(US10166214, Example 56)
Show SMILES CC(C)(COc1nccc2ccccc12)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H23N3O2/c1-19(2,22-17(23)16-14-9-20-10-15(14)16)11-24-18-13-6-4-3-5-12(13)7-8-21-18/h3-8,14-16,20H,9-11H2,1-2H3,(H,22,23)/t14-,15+,16+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
3.46E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311971
PNG
(US10166214, Example 107)
Show SMILES Cc1cccc2c(nn(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-11-15(10)22(4)21-16(11)18(2,3)20-17(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,20,23)/t12-,13+,14+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
4.30E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM50081055
PNG
(CHEMBL3421843 | US10166214, Example 49)
Show SMILES Cn1nc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
4.54E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311992
PNG
(US10166214, Example 128)
Show SMILES Cc1cccn2c(nc(C3CC3)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C20H26N4O/c1-11-5-4-8-24-17(11)16(12-6-7-12)22-19(24)20(2,3)23-18(25)15-13-9-21-10-14(13)15/h4-5,8,12-15,21H,6-7,9-10H2,1-3H3,(H,23,25)/t13-,14+,15+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
6.18E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311990
PNG
(US10166214, Example 126)
Show SMILES Cc1cccn2c(ncc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C17H22N4O/c1-10-5-4-6-21-13(10)9-19-16(21)17(2,3)20-15(22)14-11-7-18-8-12(11)14/h4-6,9,11-12,14,18H,7-8H2,1-3H3,(H,20,22)/t11-,12+,14+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
6.63E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311942
PNG
(US10166214, Example 78)
Show SMILES Cc1cc2cccnc2c(n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C18H22N4O/c1-10-7-11-5-4-6-20-15(11)16(21-10)18(2,3)22-17(23)14-12-8-19-9-13(12)14/h4-7,12-14,19H,8-9H2,1-3H3,(H,22,23)/t12-,13+,14+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
6.64E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM312012
PNG
(US10166214, Example 148)
Show SMILES Cc1nc(c2cccc(C)c2n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H24N4O/c1-10-6-5-7-12-16(10)21-11(2)22-17(12)19(3,4)23-18(24)15-13-8-20-9-14(13)15/h5-7,13-15,20H,8-9H2,1-4H3,(H,23,24)/t13-,14+,15+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
6.67E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311957
PNG
(US10166214, Example 93)
Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
7.03E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311927
PNG
(US10166214, Example 63)
Show SMILES CC(C)(COc1cnccc1C(F)(F)F)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C16H20F3N3O2/c1-15(2,22-14(23)13-9-5-21-6-10(9)13)8-24-12-7-20-4-3-11(12)16(17,18)19/h3-4,7,9-10,13,21H,5-6,8H2,1-2H3,(H,22,23)/t9-,10+,13+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>7.07E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM50081059
PNG
(CHEMBL3421845 | US10166214, Example 138)
Show SMILES Cc1nc(c2ccccc2n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C18H22N4O/c1-10-20-14-7-5-4-6-11(14)16(21-10)18(2,3)22-17(23)15-12-8-19-9-13(12)15/h4-7,12-13,15,19H,8-9H2,1-3H3,(H,22,23)/t12-,13+,15+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
7.36E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM311927
PNG
(US10166214, Example 63)
Show SMILES CC(C)(COc1cnccc1C(F)(F)F)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C16H20F3N3O2/c1-15(2,22-14(23)13-9-5-21-6-10(9)13)8-24-12-7-20-4-3-11(12)16(17,18)19/h3-4,7,9-10,13,21H,5-6,8H2,1-2H3,(H,22,23)/t9-,10+,13+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>7.51E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM311927
PNG
(US10166214, Example 63)
Show SMILES CC(C)(COc1cnccc1C(F)(F)F)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C16H20F3N3O2/c1-15(2,22-14(23)13-9-5-21-6-10(9)13)8-24-12-7-20-4-3-11(12)16(17,18)19/h3-4,7,9-10,13,21H,5-6,8H2,1-2H3,(H,22,23)/t9-,10+,13+
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>7.88E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM311927
PNG
(US10166214, Example 63)
Show SMILES CC(C)(COc1cnccc1C(F)(F)F)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C16H20F3N3O2/c1-15(2,22-14(23)13-9-5-21-6-10(9)13)8-24-12-7-20-4-3-11(12)16(17,18)19/h3-4,7,9-10,13,21H,5-6,8H2,1-2H3,(H,22,23)/t9-,10+,13+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.08E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM50081058
PNG
(CHEMBL3421842 | US10166214, Example 22)
Show SMILES Cc1cc2ccccc2c(n1)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
>8.58E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311885
PNG
(US10166214, Example 21)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1ccnc2ccccc12
Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)16-12-9-19-10-13(12)16)14-7-8-20-15-6-4-3-5-11(14)15/h3-8,12-13,16,19H,9-10H2,1-2H3,(H,21,22)/t12-,13+,16+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.58E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311875
PNG
(US10166214, Example 11)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nc2ccc(Cl)cc2[nH]1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.58E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM50081060
PNG
(CHEMBL3421844 | US10166214, Example 101)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1noc2c(F)cccc12
Show InChI InChI=1S/C16H18FN3O2/c1-16(2,19-15(21)12-9-6-18-7-10(9)12)14-8-4-3-5-11(17)13(8)22-20-14/h3-5,9-10,12,18H,6-7H2,1-2H3,(H,19,21)/t9-,10+,12+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
>8.60E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311971
PNG
(US10166214, Example 107)
Show SMILES Cc1cccc2c(nn(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-11-15(10)22(4)21-16(11)18(2,3)20-17(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,20,23)/t12-,13+,14+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.60E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM50081055
PNG
(CHEMBL3421843 | US10166214, Example 49)
Show SMILES Cn1nc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
>8.62E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311911
PNG
(US10166214, Example 47)
Show SMILES Cc1cccnc1OCC(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C16H23N3O2/c1-10-5-4-6-18-15(10)21-9-16(2,3)19-14(20)13-11-7-17-8-12(11)13/h4-6,11-13,17H,7-9H2,1-3H3,(H,19,20)/t11-,12+,13+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.62E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311904
PNG
(US10166214, Example 40)
Show SMILES Cc1ccccc1OCC(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C17H24N2O2/c1-11-6-4-5-7-14(11)21-10-17(2,3)19-16(20)15-12-8-18-9-13(12)15/h4-7,12-13,15,18H,8-10H2,1-3H3,(H,19,20)/t12-,13+,15+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.63E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311920
PNG
(US10166214, Example 56)
Show SMILES CC(C)(COc1nccc2ccccc12)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C19H23N3O2/c1-19(2,22-17(23)16-14-9-20-10-15(14)16)11-24-18-13-6-4-3-5-12(13)7-8-21-18/h3-8,14-16,20H,9-11H2,1-2H3,(H,22,23)/t14-,15+,16+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.63E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311889
PNG
(US10166214, Example 25)
Show SMILES Cc1cccnc1C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Show InChI InChI=1S/C15H21N3O/c1-9-5-4-6-17-13(9)15(2,3)18-14(19)12-10-7-16-8-11(10)12/h4-6,10-12,16H,7-8H2,1-3H3,(H,18,19)/t10-,11+,12+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.64E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311888
PNG
(US10166214, Example 24)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nccc2ccccc12
Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)15-13-9-19-10-14(13)15)16-12-6-4-3-5-11(12)7-8-20-16/h3-8,13-15,19H,9-10H2,1-2H3,(H,21,22)/t13-,14+,15+
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.65E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311957
PNG
(US10166214, Example 93)
Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.69E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Somatostatin receptor type 3


(Homo sapiens (Human))
BDBM311958
PNG
(US10166214, Example 94)
Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1n[nH]c2ccccc12
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
>8.69E+3n/an/an/an/an/an/an/an/a



Centrexion Therapeutics Corporation

US Patent


Assay Description
For the binding experiments 200 μL of membrane homogenate from one of the following protein amounts is used: hSSTR1 (40 μg/well); hSSTR2 (2...


US Patent US10166214 (2019)

More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 284 total )  |  Next  |  Last  >>
* indicates data uncertainty>20%